Study Overview: This study uses a special technology called biophotonic nanoparticles and lasers to help detect pancreatic cancer early. Pancreatic Ductal Adenocarcinoma (PDAC) is a type of cancer that affects the pancreas. The study focuses on people who are more likely to get this cancer, like those with diabetes or obesity, and helps check if treatments are working.

Eligibility: To join, you must be 18 or older, have good kidney and liver health, and no history of other cancers or blood disorders. You should also not have any serious health issues or be on treatments that might affect the study. You need to agree in writing to participate.

• Participation involves regular check-ups to monitor health.
• The study aims to improve early cancer detection and treatment effectiveness.
• Potential benefits include better understanding and management of your health risks.